Skip to main content
. 2018 Jan 25;8:1603. doi: 10.1038/s41598-017-16703-9

Figure 8.

Figure 8

Therapeutic efficacy of ND-EFV on HIV-1 infected Macrophages. HIV replication was monitored in three different conditions. The HIV-infected cells that were kept untreated served as positive control (in red). HIV-infected cells were treated with unformulated EFV (40 µg/ml) served as reference (in blue). The ND-EFV (40 µg/ml) treated cells were considered as a test (in green). In all three sets of treatments, the p24 level was monitored at a different time interval to measure the effect of treatment on HIV replication. In this case, 24h post infection was considered as day 0. Statistical significance was calculated with respect to p values (p < 0.0001).